Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evaluating Digital Device Technology in Alzheimer’s Disease via Artificial Intelligence

View ORCID ProfileMeemansa Sood, Mohamed Aborageh, View ORCID ProfileDaniel Domingo-Fernández, Robbert Harms, Thomas Lordick, Colin Birkenbihl, Andrew P Owens, Neva Coello, Vaibhav A. Narayan, Dag Aarsland, Maximilian Bügler, Holger Fröhlich, for the Alzheimer’s Disease Neuroimaging Initiative, RADAR-AD Consortium
doi: https://doi.org/10.1101/2021.11.07.21265705
Meemansa Sood
1Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), 53754 Sankt Augustin, Germany
2University of Bonn, Bonn-Aachen International Center for IT, Friedrich-Hirzebruch Allee 6, 53115 Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Meemansa Sood
  • For correspondence: meemansa.sood@scai.fraunhofer.de holger.froehlich@scai.fraunhofer.de
Mohamed Aborageh
1Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), 53754 Sankt Augustin, Germany
2University of Bonn, Bonn-Aachen International Center for IT, Friedrich-Hirzebruch Allee 6, 53115 Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Domingo-Fernández
1Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), 53754 Sankt Augustin, Germany
2University of Bonn, Bonn-Aachen International Center for IT, Friedrich-Hirzebruch Allee 6, 53115 Bonn, Germany
3Enveda Biosciences, Boulder, CO, 80301, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Domingo-Fernández
Robbert Harms
4Altoida Inc. 2100 West Loop South, Suite 1450, Houston, TX 77027, USA
5Altoida AG Hirschengraben 31, 6003, Lucerne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Lordick
1Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), 53754 Sankt Augustin, Germany
2University of Bonn, Bonn-Aachen International Center for IT, Friedrich-Hirzebruch Allee 6, 53115 Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin Birkenbihl
1Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), 53754 Sankt Augustin, Germany
2University of Bonn, Bonn-Aachen International Center for IT, Friedrich-Hirzebruch Allee 6, 53115 Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew P Owens
6Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neva Coello
7Novartis Pharmaceuticals, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vaibhav A. Narayan
8Janssen Neuroscience Research & Development, Titusville, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dag Aarsland
6Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maximilian Bügler
4Altoida Inc. 2100 West Loop South, Suite 1450, Houston, TX 77027, USA
5Altoida AG Hirschengraben 31, 6003, Lucerne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Holger Fröhlich
1Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), 53754 Sankt Augustin, Germany
2University of Bonn, Bonn-Aachen International Center for IT, Friedrich-Hirzebruch Allee 6, 53115 Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: meemansa.sood@scai.fraunhofer.de holger.froehlich@scai.fraunhofer.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The use of digital technologies may help to diagnose Alzheimer’s Disease (AD) at the pre-symptomatic stage. However, before implementation into clinical practice, digital measures (DMs) need to be evaluated for their diagnostic benefit compared to established questionnaire-based assessments, such as the Mini-Mental State Examination (MMSE) for cognition and Functional Activity Questionnaire (FAQ) for daily functioning. Moreover, the quantitative and qualitative relationship of DMs to these well understood scores needs to be clarified to aid interpretation. In this work we analyzed data from 148 subjects, 58 cognitively normal and 90 at different stages of the disease, which had performed a smartphone based virtual reality game to assess cognitive function. In addition, we used clinical data from Alzheimer’s Disease Neuroimaging Initiative (ADNI). We employed an Artificial Intelligence (AI) based approach to elucidate the relationship of DMs to questionnaire-based cognition and functional activity scores. In addition, we used Machine Learning (ML) and statistical methods to assess the diagnostic benefit of DMs compared to questionnaire-based scores. We found non-trivial relationships between DMs, MMSE, and FAQ which can be visualized as a complex network. DMs, in particular those reflecting scores of individual tasks in the virtual reality game, showed a better ability to discriminate between different stages of the disease than questionnaire-based methods. Our results indicate that DMs have the potential to act as a crucial measure in the early diagnosis and staging of AD.

Competing Interest Statement

MB and RH are employees of Altoida Inc. and Altoida AG. NC is an employee of Novartis Pharmaceuticals AG. None of the employers had any influence on the scientific content of this study.

Funding Statement

Innovative Medicines Initiative Joint Undertaking under grant agreement #IMI2-2017-12-01

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The New England Independent Review Board (NEIRB) gave the approval on 17 October 2016. IRB reference#: 120160894

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† Alzheimer’s Disease Neuroimaging Initiative: Data used in the preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf

Data Availability

The respective data owners of the data used in this publication provided access to the datasets. For ADNI, approval was received by applying for data access on http://adni.loni.usc.edu/data-samples/access-data/ web server. For Altoida, approval to use the data was provided by it’s data owners.

http://adni.loni.usc.edu/data-samples/access-data/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evaluating Digital Device Technology in Alzheimer’s Disease via Artificial Intelligence
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluating Digital Device Technology in Alzheimer’s Disease via Artificial Intelligence
Meemansa Sood, Mohamed Aborageh, Daniel Domingo-Fernández, Robbert Harms, Thomas Lordick, Colin Birkenbihl, Andrew P Owens, Neva Coello, Vaibhav A. Narayan, Dag Aarsland, Maximilian Bügler, Holger Fröhlich, for the Alzheimer’s Disease Neuroimaging Initiative, RADAR-AD Consortium
medRxiv 2021.11.07.21265705; doi: https://doi.org/10.1101/2021.11.07.21265705
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Evaluating Digital Device Technology in Alzheimer’s Disease via Artificial Intelligence
Meemansa Sood, Mohamed Aborageh, Daniel Domingo-Fernández, Robbert Harms, Thomas Lordick, Colin Birkenbihl, Andrew P Owens, Neva Coello, Vaibhav A. Narayan, Dag Aarsland, Maximilian Bügler, Holger Fröhlich, for the Alzheimer’s Disease Neuroimaging Initiative, RADAR-AD Consortium
medRxiv 2021.11.07.21265705; doi: https://doi.org/10.1101/2021.11.07.21265705

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1099)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9781)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2317)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (605)
  • Hematology (238)
  • HIV/AIDS (506)
  • Infectious Diseases (except HIV/AIDS) (11655)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (239)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2146)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (365)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (312)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2187)
  • Public and Global Health (4672)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)